ResearchMoz

Top 1000 Electronic Valves & Tubes (Global)

Plimsoll Publishing Ltd.
Published Date » 2012-07-01
No. Of Pages » 1105

This report is an in-depth financial evaluation of the GlobalElectronic Valves & Tubes. Using the unique Plimsoll method of analysis, each of the top 1000 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation. The following are some of the key findings of this new report:

157 of the 1000 companies analysed have been rated as Danger

376 companies are ripe for takeover

175 companies achieved greater than 10% increase in sales last year.

108 companies made a pre-tax loss.

237 companies saw sales fall last year
.

Our analysis gives you this unrivalled market and company intelligence using a simple graphical, numeric and model. Each company is individually analysed in both the companys own currency, and USD ($) for ease of use. These individual analyses highlight a companys strengths and weaknesses instantly.

Along with individual company information, this report also contains a comprehensive study of the market, based on the companies analysed. This key information includes:

  • Best trading partners (based on commercial and financial strength)
  • Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
  • Profitability (Profit return on assets, pre-tax profit margins, industry average)
  • Fastest growing companies (performance matrix)
Companies can change at an alarming rate in a very short space of time be sure to check out the performance of the 157 companies we rate as Danger to see how these companies have declined over 4 years. The Plimsoll Global Analysis will give you an in-depth assessment of the Global Electronic Valves & Tubes industry instantly. Whether you wish to benchmark your own companys results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.
Table Of Contents

This extensive report is broken into two parts:


1. A complete financial assessment of the market, based on the companies analysed
2. An individual financial performance analysis of each company (2 pages per company)

Specific areas included in the market assessment include
;

Section 1 - Best Trading Partners (based on commercial and financial strength)

1.1a Best Trading Partners definition and industry top 5 list
1.1b Performance matrix (Financial Strength Vs Sales Growth)
1.1c List of Best Trading Partners in the industry

Section 2 - Sales & Market Performance

2.1 Sales Growth
2.1a 4 year trend analysis
2.1b Industry Average Sales Growth
2.1c Sales Growth Ranking Table
2.1d Top 50 Companies ranked by Market Share
2.2 Sales Return on Assets
2.2a 4 year trend analysis
2.2b Sales return on total assets
2.2c Sales return on assets ranking table
2.2d Top 50 companies sales return on assets

Section 3 Profitability

3.1 Pre-tax profit margin
3.1a Pre-tax profit margin 4 year trend analysis
3.1b Industry Average pre-tax profit margin
3.1c Pre-tax profit margin ranking table
3.1d Top 50 companies actual pre-tax profit
3.2 - Pre-tax profit return on total assets
3.2a - Pre-tax profit return on total assets 4 year trend analysis
3.2b Industry average pre-tax profit return on total assets
3.2c Pre-tax profit return on total assets ranking table
3.3 - Profitability
3.3a Profitability industry average

4. 0 How to Use

5.0 Individual Company Analysis


The individual company assessment gives a complete financial picture of each company listed, including a narrative summary of the analysis. One of our key indicators is the Plimsoll Chart which combines several performance figures to give an overall measurement of the financial strength of any company. The Plimsoll chart is complied through the analysis of several different areas, including;

Sales Growth, Trading Stability, Profitability, Working Capital, Gearing and Immediate Liquidity

As all measurements are standardised, in one report you can quickly compare like with like for every major company in your industry. The accounts of each company appear in its own currency and US$ to allow comparison.

Each individual company analysis includes:

  • A full four year financial assessment, Debtor days analysis, Latest sales/profitability rankings. 
  • Employee Performance Analysis, Comparisons against industry average.
  • Overall company financial rating as read in the Plimsoll Chart, Industry ranking matrix.
  • Company analysis written summary.
Other information in the report includes;

  • Details of the Plimsoll Model
  • Definition of Terms
  • List of Shareholders
  • Global Index by region
  • Ranking Analysis by sales/profits
  • Companies considered but not included
  • Index of companies

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Poland: soups and broths market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the soups and broths market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the soups and broths market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate...
Poland: market of ceramic electrical insulators
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the ceramic electrical insulators market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the ceramic electrical insulators market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...
Poland: market of travertine, ecaussine, granite, porphyry, basalt, sandstone
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the travertine, ecaussine, granite, porphyry, basalt, sandstone market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the travertine, ecaussine, granite, porphyry, basalt, sandstone market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...
Chinese manufacturing gauge gets a hike after months
Jul 24, 2014  
China manufacturing gauge has climbed to its 18-month high this month, which has boosted the government’s chance of meeting the target for economic growth set for 2014, by a percentage of 7.5. The Purchasing Managers Index (PMI) preliminary from Markit Economics and HSBC Holdings Plc was at 52.0 and its has topped the 51.0 median estimate. These numbers indicate an above 50 mark. The...
Early Treatment to Cure HIV virus Might not be Effective
Jul 23, 2014  
According to a research study, the virus of AIDS, HIV has the capacity of creating invulnerable strongholds in the host’s body rapidly. This has dashed hopes of early treatment for the condition, which might have been helpful to cure the virus. In one case, a baby was thought to be cured with the new treatment after its birth, however, the virus emerged couple of years later. A...
Pharmaceutical Companies in Europe to Share Deprioritized Compounds for Medical Research
Jul 23, 2014  
Seven leading drugmakers in the UK have decided to share their unused experimental medicines with British researchers involved in academic research. This move is seen as an effort to deepen relations between the pharmaceutical industry and the community of scientists in the country. The new partnership between the seven pharma companies and the Medical Research Council (MRC) was...